NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal ...Middle East

PR Newswire - News
NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal
CAMBRIDGE, Mass., June 21, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, announces that it has received a notice of delisting from Nasdaq. The staff of the Listing...

Hence then, the article about neurosense receives delisting notice from nasdaq and intends to appeal was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News